Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3771113014 | Lamivudine and nevirapine and stavudine only product in oromucosal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3771114015 | Product containing only lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Lamivudine and nevirapine and stavudine only product in oromucosal dose form | Is a | Product containing lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) | true | Inferred relationship | Some | ||
Lamivudine and nevirapine and stavudine only product in oromucosal dose form | Count of base of active ingredient | 3 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
Lamivudine and nevirapine and stavudine only product in oromucosal dose form | Has manufactured dose form | Oromucosal dose form (dose form) | true | Inferred relationship | Some | ||
Lamivudine and nevirapine and stavudine only product in oromucosal dose form | Is a | Lamivudine and nevirapine and stavudine only product | true | Inferred relationship | Some | ||
Lamivudine and nevirapine and stavudine only product in oromucosal dose form | Has active ingredient | Lamivudine (substance) | true | Inferred relationship | Some | 2 | |
Lamivudine and nevirapine and stavudine only product in oromucosal dose form | Has active ingredient | Nevirapine (substance) | true | Inferred relationship | Some | 3 | |
Lamivudine and nevirapine and stavudine only product in oromucosal dose form | Has active ingredient | Stavudine (substance) | true | Inferred relationship | Some | 1 | |
Lamivudine and nevirapine and stavudine only product in oromucosal dose form | Plays role | Antiretroviral therapeutic role | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | False | Lamivudine and nevirapine and stavudine only product in oromucosal dose form | Inferred relationship | Some | |
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | False | Lamivudine and nevirapine and stavudine only product in oromucosal dose form | Inferred relationship | Some |
This concept is not in any reference sets